Mechanisms of Invariant NKT Cell Activity in Restraining Bacillus anthracis Systemic Dissemination

Area of Science:

• Immunology
• Infectious Diseases
• Microbiology

Background:

• Invariant natural killer T (iNKT) cells are crucial immune regulators.
• Exogenous activation of iNKT cells with α-galactosylceramide (α-GalCer) shows therapeutic potential in various diseases.
• Bacillus anthracis infection poses a significant biodefense threat.

Purpose of the Study:

• To investigate the efficacy of α-GalCer in protecting against Bacillus anthracis infection.
• To elucidate the immunological mechanisms underlying α-GalCer-mediated protection.

Main Methods:

• Utilized a mouse model of subcutaneous B. anthracis infection.
• Administered α-GalCer concomitantly with bacterial challenge.
• Depleted subcapsular sinus CD169-positive macrophages using clodronate liposomes.
• Assessed bacterial dissemination, survival rates, and immune cell activation in draining lymph nodes (dLNs).

Main Results:

• Concomitant α-GalCer administration delayed B. anthracis systemic spread and prolonged mouse survival.
• Depletion of CD169+ macrophages abrogated iNKT cell activation and the protective effects of α-GalCer.
• α-GalCer treatment induced IFN-γ production, chemokine (C-C motif) ligand 3 synthesis, and neutrophil recruitment in dLNs.
• These events collectively restrained B. anthracis dissemination from the dLNs.

Conclusions:

• α-GalCer immunotherapy offers protection against B. anthracis infection.
• The protective mechanism involves iNKT cell activation, macrophage-dependent processes, and subsequent neutrophil recruitment.
• This study reveals a novel immunological pathway for controlling anthrax, suggesting potential for iNKT cell-based therapeutics.